安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Risk-benefit Analysis - Hazard Analysis (HA) and FMEAs
But sometimes this risk manager involves production staff and developers to his risk management meetings and they say: wait a second, we already did that job before and risk manager is either happy for the already done work or is confused And then they start to mix up both worlds in a very complicated or senseless or even non-conforming way
- Risk Benefit Analysis - ISO 14971:2012 Requirements - The Elsmar Cove . . .
Risk benefit analysis is introduced to risk analysis by ISO TR 24971:2013 Since there isn't any statistical data best way to close each individual residual risk is risk benefit analysis Since most of medical device manufacturers don't care anything they are reducing all risks to acceptable level, people are insisting risk benefit analysis to
- Benefit risk analysis on pFMEA - Elsmar Cove Quality and Business . . .
Some Notified Bodies will require an individual risk benefit analysis for lines of analysis in FMEA, even if they are completely subordinate to a Hazard Analysis It doesn't make sense to me, but they will consider your implementation of 14971 deficient
- Risk-benefit Analysis - Hazard Analysis (HA) and FMEAs
The reason is that FMEA (and other design engineering techniques) focus on DEVICE FAILURE, or as earlier dubbed "the specification", while clinical risk may be present with a perfectly performing device, i e a device 100% at par with its spec That's why an ISO 14971 compliant risk management process will benefit from both types of input
- What are suitable indicators and threshold values in MDR IVDR?
The statistical analysis provides "threshold values" (3 standard deviations with SPC and other rules) that something about your risk is CHANGING This may be more important than the actual value of the risk level, this is an alarm to determine what is the source of the change and is it a "good thing" or a "bad thing"
- Risk benefit Analysis in Risk Management Report - The Elsmar Cove . . .
While I agree, it's not necessarily the position taken by 14971:2012 This is a rather well-debated subject I've had a several reviewers (test labs, tech file, etc ) insist that, if we want to claim compliance to 14971:2012 then we have to do a risk-benefit analysis on each risk
- Risk benefit Analysis in Risk Management Report - Page 2
1 Risk vs benefit is not applicable for all the risk since you might have already mitigated some of the risks to lower RPN 2 Risk vs benefit is done only when there exists a risk after mitigation which is beyond your acceptable tolerance 3 You need to specify the risk and what are its end level effects can be declared as side-effects in
- Overall Benefit Risk Analysis - Risk Management VS Clinical Evaluation
As part of our clinical evaluation process, a benefit risk analysis is also documented in the Clinical Evaluation Report Currently, we use the exact same wording for the benefit risk analysis in both reports This makes some things logistically inefficient like not being able to update one report without updating the other
|
|
|